These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 32791185)

  • 1. The ACTN3 577XX Null Genotype Is Associated with Low Left Ventricular Dilation-Free Survival Rate in Patients with Duchenne Muscular Dystrophy.
    Nagai M; Awano H; Yamamoto T; Bo R; Matsuo M; Iijima K
    J Card Fail; 2020 Oct; 26(10):841-848. PubMed ID: 32791185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum cardiac troponin I is a candidate biomarker for cardiomyopathy in Duchenne and Becker muscular dystrophies.
    Yamaguchi H; Awano H; Yamamoto T; Nambu Y; Iijima K
    Muscle Nerve; 2022 May; 65(5):521-530. PubMed ID: 35174514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The ACTN3 R577X polymorphism is associated with inflammatory myopathies in a Mexican population.
    Sandoval-García F; Petri MH; Saavedra MA; Cruz-Reyes CV; Jara-Quezada LJ; Dávalos-Rodríguez IP; Salazar-Páramo M; Gámez-Nava JI; González-López L; García-Iglesias T; Corona-Sánchez EG; Zavaleta-Muñiz S; Vargas-Ramírez R; Vázquez-Del Mercado M; Martín-Márquez BT
    Scand J Rheumatol; 2012 Oct; 41(5):396-400. PubMed ID: 22639897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ACTN3 R577X Polymorphism Is Associated With the Incidence and Severity of Injuries in Professional Football Players.
    Massidda M; Voisin S; Culigioni C; Piras F; Cugia P; Yan X; Eynon N; Calò CM
    Clin J Sport Med; 2019 Jan; 29(1):57-61. PubMed ID: 28817413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for ACTN3 as a genetic modifier of Duchenne muscular dystrophy.
    Hogarth MW; Houweling PJ; Thomas KC; Gordish-Dressman H; Bello L; ; Pegoraro E; Hoffman EP; Head SI; North KN
    Nat Commun; 2017 Jan; 8():14143. PubMed ID: 28139640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is evolutionary loss our gain? The role of ACTN3 p.Arg577Ter (R577X) genotype in athletic performance, ageing, and disease.
    Houweling PJ; Papadimitriou ID; Seto JT; Pérez LM; Coso JD; North KN; Lucia A; Eynon N
    Hum Mutat; 2018 Dec; 39(12):1774-1787. PubMed ID: 30281865
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Del Coso J; Moreno V; Gutiérrez-Hellín J; Baltazar-Martins G; Ruíz-Moreno C; Aguilar-Navarro M; Lara B; Lucía A
    Genes (Basel); 2019 May; 10(6):. PubMed ID: 31146466
    [No Abstract]   [Full Text] [Related]  

  • 8. ACTN3 R577X polymorphism and long-term survival in patients with chronic heart failure.
    Bernardez-Pereira S; Santos PC; Krieger JE; Mansur AJ; Pereira AC
    BMC Cardiovasc Disord; 2014 Jul; 14():90. PubMed ID: 25059829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics and outcomes of cardiomyopathy in children with Duchenne or Becker muscular dystrophy: a comparative study from the Pediatric Cardiomyopathy Registry.
    Connuck DM; Sleeper LA; Colan SD; Cox GF; Towbin JA; Lowe AM; Wilkinson JD; Orav EJ; Cuniberti L; Salbert BA; Lipshultz SE;
    Am Heart J; 2008 Jun; 155(6):998-1005. PubMed ID: 18513510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ACTN3 R577X genotypes associate with Class II and deepbite malocclusions.
    Zebrick B; Teeramongkolgul T; Nicot R; Horton MJ; Raoul G; Ferri J; Vieira AR; Sciote JJ
    Am J Orthod Dentofacial Orthop; 2014 Nov; 146(5):603-11. PubMed ID: 25439211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Effect of Heterozygosity for the ACTN3 Null Allele on Human Muscle Performance.
    Garton FC; North KN
    Med Sci Sports Exerc; 2016 Mar; 48(3):509-20. PubMed ID: 26429734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Are 'endurance' alleles 'survival' alleles? Insights from the ACTN3 R577X polymorphism.
    Fiuza-Luces C; Ruiz JR; Rodríguez-Romo G; Santiago C; Gómez-Gallego F; Yvert T; Cano-Nieto A; Garatachea N; Morán M; Lucia A
    PLoS One; 2011 Mar; 6(3):e17558. PubMed ID: 21407828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of
    Gutiérrez-Hellín J; Baltazar-Martins G; Aguilar-Navarro M; Ruiz-Moreno C; Oliván J; Del Coso J
    Genes (Basel); 2021 Jan; 12(1):. PubMed ID: 33430120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association analysis of the ACTN3 R577X polymorphism with passive muscle stiffness and muscle strain injury.
    Miyamoto N; Miyamoto-Mikami E; Hirata K; Kimura N; Fuku N
    Scand J Med Sci Sports; 2018 Mar; 28(3):1209-1214. PubMed ID: 29032593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between the ACTN3 R577X polymorphism and artistic gymnastic performance in Italy.
    Massidda M; Vona G; Calò CM
    Genet Test Mol Biomarkers; 2009 Jun; 13(3):377-80. PubMed ID: 19405879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiac Dysfunction in Duchenne Muscular Dystrophy Is Less Frequent in Patients With Mutations in the Dystrophin Dp116 Coding Region Than in Other Regions.
    Yamamoto T; Awano H; Zhang Z; Sakuma M; Kitaaki S; Matsumoto M; Nagai M; Sato I; Imanishi T; Hayashi N; Matsuo M; Iijima K; Saegusa J
    Circ Genom Precis Med; 2018 Jan; 11(1):e001782. PubMed ID: 29874176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. More than a 'speed gene': ACTN3 R577X genotype, trainability, muscle damage, and the risk for injuries.
    Del Coso J; Hiam D; Houweling P; Pérez LM; Eynon N; Lucía A
    Eur J Appl Physiol; 2019 Jan; 119(1):49-60. PubMed ID: 30327870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of the ACTN3 R577X genotype on the injury epidemiology of marathon runners.
    Moreno V; Areces F; Ruiz-Vicente D; Ordovás JM; Del Coso J
    PLoS One; 2020; 15(1):e0227548. PubMed ID: 31990958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strength, power, fiber types, and mRNA expression in trained men and women with different ACTN3 R577X genotypes.
    Norman B; Esbjörnsson M; Rundqvist H; Osterlund T; von Walden F; Tesch PA
    J Appl Physiol (1985); 2009 Mar; 106(3):959-65. PubMed ID: 19150855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect and safety of treatment with ACE-inhibitor Enalapril and β-blocker metoprolol on the onset of left ventricular dysfunction in Duchenne muscular dystrophy - a randomized, double-blind, placebo-controlled trial.
    Dittrich S; Graf E; Trollmann R; Neudorf U; Schara U; Heilmann A; von der Hagen M; Stiller B; Kirschner J; Pozza RD; Müller-Felber W; Weiss K; von Au K; Khalil M; Motz R; Korenke C; Lange M; Wilichowski E; Pattathu J; Ebinger F; Wiechmann N; Schröder R;
    Orphanet J Rare Dis; 2019 May; 14(1):105. PubMed ID: 31077250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.